Manica Balasegaram: “Multi-resistant bacteria are just as threatening”
Faced with antibiotic resistance, pharmaceuticals and governments could be doing much more, warns Manica Balasegaram, Executive Director of GARDP, in an interview with French magazine Le Temps.
The current pandemic could have been avoided if measures had been taken to prevent it and if the pharmaceutical companies had been encouraged to find treatments. In the same vein, other equally inevitable global health problems could have been countered if we had acted earlier. This includes antibiotic-resistant bacteria in particular, a growing threat to humanity against which pharmaceutical companies are not doing much. This is the opinion of Manica Balasegaram, a British and Swiss doctor who has treated patients in the four corners of the globe before joining the Global Antibiotic Research and Development Partnership (GARDP), a Swiss foundation created in 2019 in Geneva.
Read the translated version of the interview here: